The bioanalytical lab at Resilience has significant experience developing and working with biologic products, including biosimilars, vaccines, and biomarkers in different therapeutic areas.
Our scientists have over 10 years of experience in bioanalytical method development, validation, and sample testing dedicated to biologics development in contract research organization (CRO) environments and pharmaceutical industries. We work collaboratively to effectively meet Sponsors’ requirements of accurate, timely, and high-quality data.
We have Standard Operating Procedures (SOPs) in place to ensure compliance with good laboratory practice (GLP) and good clinical laboratory practice (GCLP) standards as well as current regulatory guidelines.
Resilience has successfully completed Department of Defense (DOD) inspection for multiple biodefense programs proving our deep understanding of regulatory guidelines, and demonstrating quality and integrity of our nonclinical and clinical bioanalytical data.